GLP-1 Receptor Agonists Linked to Lower Mortality for Patients With Brain Metastases, T2DM

Summary: A recent study shows that a popular type of diabetes medicine, called GLP-1s, could be a major lifesaver for people with Type 2 diabetes who also have cancer that has spread to the brain. Researchers looked at patients taking these medicines and found they had a much lower chance of dying compared to those who did not take them. The medicines seem to help by lowering brain swelling, keeping the brain's natural protective shield strong, and reducing stress on the cells. It turns out this common diabetes treatment is doing a lot of heavy lifting to protect brain health!

For more details, see rssapp-neurologyadvisor-com at neurologyadvisor.com/news/glp-1-receptor-agonists-linked-to-lower-mortality-for-patients-with-brain-metastases-t2dm/ (opens in new tab)